CA43207-1 - 0x00000000000061E6
Males & Females of Non-Childbearing Potential
River
* Stipend may pay up to reflected amount.
Start Date:
May 29, 2024 - 1:00pm
End Date:
June 26, 2024 - 9:30am
Study Details
Study Number: CA43207
Group Number: 1
Study Requirement: Healthy Normal Male and Female
Stipend: up to $7,000.00
Study Criteria
Age: 19 - 55
BMI: 18 - 32
Weight Restriction: minimum weight 0 lbs
Study Information
Indication: This investigational medication is being developed to treat cancer.
Route of Administration: Oral
Blood Draws: 33
Study Schedule
Schedule Type: Long Term
Study Length: 3 - Night Stay, 8 - Night Stay & 1 Return
Screening Dates:
| Event Day | Event Date |
|---|---|
| Monday | 5/20/2024 |
| Friday | 5/24/2024 |
| Tuesday | 5/28/2024 |
| Wednesday | 5/29/2024 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Monday | 5/20/2024 |
| Friday | 5/24/2024 |
| Tuesday | 5/28/2024 |
| Wednesday | 5/29/2024 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Wednesday | 5/29/2024 1:00:00 PM | Saturday | 6/1/2024 7:30:00 AM | 1 | Lincoln |
| Check-In | Wednesday | 6/5/2024 1:00:00 PM | Thursday | 6/13/2024 9:30:00 AM | 2 | Lincoln |
| Return | Wednesday | 6/26/2024 8:30:00 AM | Wednesday | 6/26/2024 9:30:00 AM | 2 | Lincoln |
